Katharina Büerger

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

Katharina Büerger, Michael Ewers, Tuula Pirttilä et al. · Brain · 2006 · 584 citations

Alzheimer's Disease, Neocortical Neurofibrillary Pathology, Dementia +14

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Henryk Barthel, Hermann‐Josef Gertz, S. Dresel et al. · The Lancet Neurology · 2011 · 574 citations

Neurodegenerative Diseases, Diagnostic Study, Alzheimer's Disease +7

Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease

Harald Hampel, Katharina Büerger, Raymond Zinkowski et al. · Archives of General Psychiatry · 2004 · 430 citations

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Itziar de Rojas, Sonia Moreno–Grau, Niccoló Tesi et al. · Nature Communications · 2021 · 320 citations · Full text

Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment

Harald Hampel, Stefan Teipel, Tanja Fuchsberger et al. · Molecular Psychiatry · 2003 · 291 citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +8